Large-Joint Reconstructive Implants – Market Insights – Asia Pacific (Supplemental)

The Asia Pacific large-joint reconstructive implant market was limited by the COVID-19 pandemic given that many hip and knee implant procedures are considered elective; however, the market continues to recover, with growth owing to favorable demographics, rising adoption of innovative devices, and demand for technologies that provide better patient outcomes. Budgetary constraints among many Asia Pacific facilities will nonetheless result in slower adoption of premium-priced technologies that will hinder revenue potential to some degree.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for Large-joint reconstructive implants in the Asia Pacific region from 2019 through 2031.

Table of contents